Lenalidomid Approved by FDA for Follicular and Marginal Zone Lymphoma

This thalidomide analogue is also indicated for multiple myeloma and myelodysplastic syndromes.

Source: CancerNetwork - May 28, 2019 Category: Cancer & Oncology Authors: Drew Boxler Source Type: news